CPIX – cumberland pharmaceuticals inc. (US:NASDAQ)

News

Zacks Initiates Coverage of CPIX With Outperform Recommendation [Yahoo! Finance]
CALDOLOR® (IBUPROFEN) INJECTION CMS ISSUED J-CODE NOW ASSOCIATED WITH REIMBURSEMENT PRICE SUPPORTING NON-OPIOID PAIN MANAGEMENT
Cumberland Pharmaceuticals (NASDAQ:CPIX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Cumberland Pharmaceuticals (NASDAQ:CPIX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com